This treatment resulted in a significant increase of ROS and HIF-1α in all ovarian cancer cells (Fig. 7), suggesting that ovarian cancer cells generate an oxidative stress response to counteract olaparib treatment (54, 70), potentially through changes in the metabolism of mitochondria (102). Here, HIF1A is linked to ovarian cancer.